CLINICAL UNIT FOR THE ANGIOGRAPHIC TRIAL IN WOMEN

该计划的目的是评估激素替代是否 治疗和/或抗氧化剂治疗将稳定或抑制进展， 并诱导女性冠状动脉斑块消退。 第1阶段（8个月）包括计划和组织研究方案， 操作手册和数据表格。方案开发将 大约6个月。在方案开发之后，将有一个 研究活动中断约2个月。这段时间 参与中心将根据以下内容编制并提交修订后的成本提案： 在实际的协议上。第11期（4年）将招募患者 和患者随访。第111阶段（6个月）用于数据分析。

The purpose of this program is to assess whether hormonal replacement therapy and/or antioxidant treatment will stabilize or inhibit progression, and induce regression of coronary plaques in women. Phase 1 (8 months) comprises planning and organizing the Study Protocols, Manual of Operations, and data forms. Protocol Development will take approximately 6 months. After Protocol Development, there will be an approximate 2 month hiatus in activity on the study. During this time, the participating centers will prepare and submit revised cost proposals based on the actual protocol. Phase 11(4 years) will be Thr patient recruitment and patient follow-up. Phase 111(6 months) is for data analysis.